Crescent Capital BDC, Inc. (CCAP)

In the past six months, Crescent Capital BDC's stock has experienced analyst activities and earnings-related movements. The company has a consensus rating of "Moderate Buy" from analysts. Oppenheimer cut its price objective from $20.00 to $19.00, while Wells Fargo & Company reduced its price target from $15.00 to $14.00 in November 2025. Zacks Research lowered its rating on CCAP from "hold" to "strong sell" in January 2026, and Wall Street Zen upgraded the stock from "sell" to "hold" in January 2026. Following its Q3 2025 earnings report, CCAP shares declined by 4.5%, but subsequently increased by 9.3% over the next 70 days. The latest closing stock price as of February 6, 2026, was $14.40. Crescent Capital BDC also declared a quarterly dividend of $0.42 per share with an ex-date of December 31, 2025, and a payment date of January 15, 2026. The next estimated dividend of $0.42 per share has an ex-date of March 31, 2026, and a payment date of April 15, 2026.

There is no specific information available regarding demand seasonality for Crescent Capital BDC, Inc.'s products and services. The demand for its services is typically influenced by broader economic conditions and the capital needs of its target companies rather than seasonal consumer trends.

Crescent Capital BDC, Inc. is a closed-end, externally managed business development company that provides flexible financing solutions to private middle-market companies primarily in the United States. The company aims to generate income through interest payments and capital appreciation through equity co-investments. Crescent Capital BDC's investment strategy focuses on a diversified portfolio of debt and equity instruments, including senior secured loans, unsecured second-lien loans, mezzanine debt, and preferred and common equity co-investments. The company partners with management teams across various industries to support growth initiatives, acquisitions, refinancings, and recapitalizations. Crescent Capital BDC is externally managed by Crescent Capital Group.

Crescent Capital BDC, Inc. primarily focuses its investments on private middle-market companies located in the United States. Its external manager, Crescent Capital Group, maintains a broader operational presence with offices in Los Angeles, New York, Boston, Chicago, and London.

Crescent Capital BDC, Inc. generally holds a "Moderate Buy" consensus rating from analysts, indicating a somewhat positive sentiment within the investment community. Analyst rating adjustments and price target changes have occurred, but no specific events have significantly impacted the company's overall brand reputation beyond typical market and analyst evaluations.

Crescent Capital BDC, Inc. has a significant institutional ownership base, with 105 institutional owners and shareholders holding a total of 25,148,077 shares. Major institutional owners include Texas County & District Retirement System, Blackstone Group Inc, Fidelity National Financial, Inc., Sun Life Financial Inc, Franklin Resources Inc, Ares Management Llc, Putnam ETF Trust - Putnam BDC ETF -, Mariner, LLC, Bulldog Investors, LLP, and CF Capital LLC. Institutions collectively hold 58.33% of the shares outstanding, while individuals/insiders hold 1.15%, PE/VC firms hold 11.37%, and public/other investors hold 29.16%.